These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 37161761)

  • 21. Association of patient navigation with care coordination in an Lynch syndrome screening program.
    Miesfeldt S; Feero WG; Lucas FL; Rasmussen K
    Transl Behav Med; 2018 May; 8(3):450-455. PubMed ID: 29800403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges.
    Marquez E; Geng Z; Pass S; Summerour P; Robinson L; Sarode V; Gupta S
    Genet Med; 2013 Dec; 15(12):925-32. PubMed ID: 23598716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organizational readiness to implement population-based screening and genetic service delivery for hereditary cancer prevention and control.
    Knerr S; West KM; Angelo FA
    J Genet Couns; 2020 Oct; 29(5):867-876. PubMed ID: 31967362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.
    Vasen HF; Möslein G; Alonso A; Aretz S; Bernstein I; Bertario L; Blanco I; Bulow S; Burn J; Capella G; Colas C; Engel C; Frayling I; Rahner N; Hes FJ; Hodgson S; Mecklin JP; Møller P; Myrhøj T; Nagengast FM; Parc Y; Ponz de Leon M; Renkonen-Sinisalo L; Sampson JR; Stormorken A; Tejpar S; Thomas HJ; Wijnen J; Lubinski J; Järvinen H; Claes E; Heinimann K; Karagiannis JA; Lindblom A; Dove-Edwin I; Müller H
    Fam Cancer; 2010 Jun; 9(2):109-15. PubMed ID: 19763885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
    Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
    Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of the PRED-IdF, a regional network dedicated to patients with hereditary predisposition to digestive cancers].
    Perrod G; Samaha E; Bats AS; Cellier C
    Ann Pathol; 2020 Apr; 40(2):114-119. PubMed ID: 32199653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to guidelines for the referral of patients with colorectal cancer and abnormal tumour tissue testing for assessment of Lynch syndrome.
    Han J; Spigelman AD
    ANZ J Surg; 2019 Oct; 89(10):1281-1285. PubMed ID: 30856687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.
    Cross DS; Rahm AK; Kauffman TL; Webster J; Le AQ; Spencer Feigelson H; Alexander G; Meier P; Onitilo AA; Pawloski PA; Williams AE; Honda S; Daida Y; McCarty CA; Goddard KA;
    Genet Med; 2013 Dec; 15(12):933-40. PubMed ID: 23639899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
    Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
    J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification?
    Byfield SA; Syngal S
    Am J Gastroenterol; 2008 Nov; 103(11):2837-40. PubMed ID: 19032469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent of Pedigree Required to Screen for and Diagnose Hereditary Nonpolyposis Colorectal Cancer: Comparison of Simplified and Extended Pedigrees.
    Heo Y; Kim MH; Kim DW; Lee SA; Bang S; Kim MJ; Oh HK; Kang SB; Kang SI; Park JW; Ryoo SB; Jeong SY; Park KJ
    Dis Colon Rectum; 2020 Feb; 63(2):152-159. PubMed ID: 31842160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocol.
    Taylor N; Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Braithwaite J; Chin M
    BMC Health Serv Res; 2016 Mar; 16():89. PubMed ID: 26969429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
    Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population Screening for Hereditary Colorectal Cancer.
    Hampel H
    Surg Oncol Clin N Am; 2018 Apr; 27(2):319-325. PubMed ID: 29496092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review.
    Weissman SM; Bellcross C; Bittner CC; Freivogel ME; Haidle JL; Kaurah P; Leininger A; Palaniappan S; Steenblock K; Vu TM; Daniels MS
    J Genet Couns; 2011 Feb; 20(1):5-19. PubMed ID: 20931355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic testing by cancer site: colon (nonpolyposis syndromes).
    Senter L
    Cancer J; 2012; 18(4):334-7. PubMed ID: 22846734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
    Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
    Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.